Market Tracker

07/29 5:16pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

7.77
Delayed Data
As of Jul 29
 +0.04 / +0.52%
Today’s Change
5.18
Today|||52-Week Range
11.26
-25.07%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close7.73
Today’s open7.68
Day’s range7.68 - 8.07
Volume1,023,010
Average volume (3 months)1,301,613
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+13.88%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book21.81

Competitors

 Today’s
change
Today’s
% change
ALDRAlder Biopharmaceuti...+1.57+5.14%
PBYIPuma Biotechnology I...+1.37+2.82%
HCMHutchison China Medi...+0.02+0.15%
SAGESAGE Therapeutics In...+0.06+0.13%
Data as of 4:01pm ET, 07/29/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts